Cargando…
Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk
Although our understanding of psychotic disorders has advanced substantially in the past few decades, very little has changed in the standard of care for these illnesses since the development of atypical anti-psychotics in the 1990s. Here, we integrate new insights into the pathophysiology with the...
Autores principales: | Barron, Henry, Hafizi, Sina, Andreazza, Ana C., Mizrahi, Romina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372663/ https://www.ncbi.nlm.nih.gov/pubmed/28304340 http://dx.doi.org/10.3390/ijms18030651 |
Ejemplares similares
-
S169. MICROGLIAL ACTIVATION AND MORPHOLOGICAL BRAIN ALTERATIONS IN PSYCHOSIS AND PSYCHOSIS RISK
por: Hafizi, Sina, et al.
Publicado: (2018) -
Glutathione, the Major Redox Regulator, in the Prefrontal Cortex of Individuals at Clinical High Risk for Psychosis
por: Da Silva, Tania, et al.
Publicado: (2017) -
Interaction between peripheral and central immune markers in clinical high risk for psychosis
por: Nisha Aji, Kankana, et al.
Publicado: (2023) -
Mitochondrial function in individuals at clinical high risk for psychosis
por: Da Silva, Tania, et al.
Publicado: (2018) -
Personality traits in psychosis and psychosis risk linked to TSPO expression: a neuroimmune marker
por: Gerritsen, Cory, et al.
Publicado: (2020)